business

Oppenheimer reiterates Nurix stock rating after Roche deal

Investing.com · Jun 8, 2026, 3:35 PM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Roche Inks $2.3 Billion Deal, Sending This Small Biotech Stock Flying Yahoo Finance Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock Yahoo Finance Morgan Stanley Maintains Hold Rating on Fiserv (FISV) Stock

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Oppenheimer reiterates Nurix stock rating after Roche deal

Also covered by

More in business